These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31109259)

  • 1. High density lipoprotein coated calcium carbonate nanoparticle for chemotherapy of breast cancer.
    Wei K; Zhang J; Li X; Shi P; Fu P
    J Biomater Appl; 2019 Aug; 34(2):178-187. PubMed ID: 31109259
    [No Abstract]   [Full Text] [Related]  

  • 2. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fullerene as a doxorubicin nanotransporter for targeted breast cancer therapy: Capillary electrophoresis analysis.
    Kepinska M; Kizek R; Milnerowicz H
    Electrophoresis; 2018 Sep; 39(18):2370-2379. PubMed ID: 29931716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.
    Imanimoghadam M; Yaghoobi E; Alizadeh F; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    J Pharm Sci; 2024 Jul; 113(7):1865-1873. PubMed ID: 38342338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy.
    Xue T; Xu C; Wang Y; Wang Y; Tian H; Zhang Y
    Biomater Sci; 2019 Nov; 7(11):4615-4623. PubMed ID: 31441464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 8. X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy.
    Starkewolf ZB; Miyachi L; Wong J; Guo T
    Chem Commun (Camb); 2013 Mar; 49(25):2545-7. PubMed ID: 23423224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of a Sustained Release Docetaxel Loaded Cockle Shell-Derived Calcium Carbonate Nanoparticles against Breast Cancer.
    Hammadi NI; Abba Y; Hezmee MNM; Razak ISA; Jaji AZ; Isa T; Mahmood SK; Zakaria MZAB
    Pharm Res; 2017 Jun; 34(6):1193-1203. PubMed ID: 28382563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile preparation of phospholipid-amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration.
    Wang C; Liu X; Chen S; Hu F; Sun J; Yuan H
    Chem Commun (Camb); 2018 Nov; 54(93):13080-13083. PubMed ID: 30383877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-L-ornithine/fucoidan-coated calcium carbonate microparticles by layer-by-layer self-assembly technique for cancer theranostics.
    Wang P; Kankala RK; Fan J; Long R; Liu Y; Wang S
    J Mater Sci Mater Med; 2018 May; 29(5):68. PubMed ID: 29748879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
    Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
    Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Effective Drug Delivery and Cell Imaging Using Fluorescent Double-Imprinted Nanoparticles by Targeting Recognition of the Epitope of Membrane Protein.
    Qin YT; Peng H; He XW; Li WY; Zhang YK
    Anal Chem; 2019 Oct; 91(20):12696-12703. PubMed ID: 31532634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery and pH-responsive release of doxorubicin to cancer cells using calcium carbonate/hyaluronate/glutamate mesoporous hollow spheres.
    Guo Y; Li H; Shi W; Zhang J; Feng J; Yang X; Wang K; Zhang H; Yang L
    J Colloid Interface Sci; 2017 Sep; 502():59-66. PubMed ID: 28477470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy.
    Kang KW; Chun MK; Kim O; Subedi RK; Ahn SG; Yoon JH; Choi HK
    Nanomedicine; 2010 Apr; 6(2):210-3. PubMed ID: 20060074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced combination cancer therapy using lipid-calcium carbonate/phosphate nanoparticles as a targeted delivery platform.
    Wu Y; Gu W; Xu ZP
    Nanomedicine (Lond); 2019 Jan; 14(1):77-92. PubMed ID: 30543136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-pot green synthesis of doxorubicin loaded-silica nanoparticles for in vivo cancer therapy.
    Jiang S; Hua L; Guo Z; Sun L
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():257-263. PubMed ID: 29853089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
    Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.